Biotechnology Stocks I Performance Guide: BeiGene, Ltd. (BGNE)
BGNE has no dividends.
Table and Chart of BGNE Performance
See what a $1,000 investment in BGNE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BGNE Returns | |
|---|---|
| Start Date | Mar-31-2016 |
| Start Price | $29.31 |
| End Date | May-07-2024 |
| End Price | $160.56 |
| # Prices | 99 |
| Min Date | Jul-29-2016 |
| Min Price | $26.24 |
| Max Date | Sep-30-2021 |
| Max Price | $363.00 |
| Total Return | 447.80% |
| Annualized Return | 22.89% |
| Current Value of $1,000 Purchase | $5,478 |
| Number Returns | 4,851 |
| Average Return | 163.68% |
| Number Profitable Returns | 3,653 |
| Percent Profitable Returns | 75.30% |
| Number Unprofitable Returns | 1,198 |
| Percent Unprofitable Returns | 24.70% |
| Profitable to Unprofitable Returns Ratio | 3.05 |
| BGNE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $17,965,900,000 |
| Beta | 0.627 | Price to Sales | 6.34 |
| Earnings per Share | $-8.4500 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 4.174 |
| PRICE DATA | |
| 52 Week High | $245.74 |
| 52 Week Low | $126.97 |
| Analyst Target Price | $272.52 |
| 50-Day Moving Average | $155.66 |
| 200-Day Moving Average | $175.14 |
| FINANCIAL DATA | |
| Revenue per Share | $23.55 |
| Revenue | $2,458,779,000 |
| Profit Margin | -35.9% |
| Return on Equity | -22.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BGNE Compare Returns with S&P 500
BGNE Trendline Chart
BGNE Moving Average Chart
BGNE Stock Return Map - See Patterns of Gains and Losses
BGNE Stock Returns/Purchase Dates